Wisconsin AB 512: Relating to: prescription drug cost reporting by manufacturers and providing a penalty.

Status: Failed to pass pursuant to Senate Joint Resolution 1 (as of 2022-03-15)

State: Wisconsin · Session: 2021 · Bill: AB 512

Sponsors: Andraca, Bowen, Cabral-Guevara, Cabrera, Conley, Hebl, Neubauer, Pope, Shankland, Shelton, Sinicki, Snodgrass, Spreitzer, Vining, Vruwink

View Wisconsin AB 512 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.